Suppr超能文献

一种新型水溶性多巴胺 -2 拮抗剂,在胃肠运动活动中具有抗胆碱酯酶活性。与多潘立酮和新斯的明的比较。

A novel water-soluble dopamine-2 antagonist with anticholinesterase activity in gastrointestinal motor activity. Comparison with domperidone and neostigmine.

作者信息

Iwanaga Y, Miyashita N, Morikawa K, Mizumoto A, Kondo Y, Itoh Z

机构信息

Central Research Laboratories, Hokuriku Seiyaku Co. Ltd., Fukui, Japan.

出版信息

Gastroenterology. 1990 Aug;99(2):401-8. doi: 10.1016/0016-5085(90)91022-x.

Abstract

A novel water-soluble dopamine-2 antagonist, N-[4-[2-(dimethylamino) ethoxy]benzyl]-3,4-dimethoxybenzamide hydrochloride (HSR-803) was synthesized and assayed for its gastrointestinal smooth muscle stimulating activity in vivo and in vitro. In the in vivo study, gastrointestinal contractile activity was measured by means of chronically implanted force transducers in conscious dogs; it was found that HSR-803 at 3.0 mg/kg IV probably stimulated gastric contractile force twice during the digestive state and significantly antagonized dopamine-(1.0 mg/kg per hour) inhibited gastric contractions in doses of 0.3, 1, and 3 mg/kg IV. With a background IV infusion of HSR-803 at 3 mg/kg per hour, the contraction-stimulating activity of acetylcholine (0.05 mg/kg per minute) was greatly enhanced while the response to bethanechol was not changed. As a result, HSR-803 was found to have a strong anticholinesterase activity besides the antidopamine-2 activity; i.e., the anticholinesterase activity of HSR-803 at 3 mg/kg per hour was equivalent to that of neostigmine at 10 micrograms/kg per hour, and dopamine-2 antagonistic activity of HSR-803 was similar to that of domperidone on a weight basis. No symptom suggesting actions on the central nervous system was noticed in HSR-803 up to 10 mg/kg IV in conscious dogs. In the in vitro study, HSR-803 inhibited cholinesterase dose-dependently, and IC50 was 2.9 x 10(-6) mol/L, while those of neostigmine and domperidone were 2.3 x 10(-8) mol/L and 1.7 x 10(-5) mol/L, respectively. In conclusion, HSR-803 stimulates endogenous acetylcholine release by antagonizing the dopamine-2 receptor on the postsynaptic cholinergic neurons, and the anticholinesterase activity of HSR-803 may cause the released acetylcholine to accumulate at cholinergic receptor sites. Thus, HSR-803 is potentially capable of enhancing cholinergic activity in the gastrointestinal region.

摘要

合成了一种新型水溶性多巴胺 -2 拮抗剂,N - [4 - [2 - (二甲氨基)乙氧基]苄基]-3,4 - 二甲氧基苯甲酰胺盐酸盐(HSR - 803),并对其体内外胃肠道平滑肌刺激活性进行了测定。在体内研究中,通过在清醒犬体内长期植入的力传感器来测量胃肠道收缩活性;结果发现,静脉注射3.0mg/kg的HSR - 803在消化状态下可能刺激胃收缩力两次,并且在静脉注射0.3、1和3mg/kg剂量时能显著拮抗多巴胺(每小时1.0mg/kg)对胃收缩的抑制作用。在每小时3mg/kg的HSR - 803静脉背景输注下,乙酰胆碱(每分钟0.05mg/kg)的收缩刺激活性大大增强,而对氨甲酰甲胆碱的反应未改变。结果发现,HSR - 803除具有抗多巴胺 -2 活性外,还具有较强的抗胆碱酯酶活性;即每小时3mg/kg的HSR - 803的抗胆碱酯酶活性相当于每小时10μg/kg的新斯的明的活性,且HSR - 803的多巴胺 -2 拮抗活性在重量基础上与多潘立酮相似。在清醒犬静脉注射高达10mg/kg的HSR - 803时,未观察到提示对中枢神经系统有作用的症状。在体外研究中,HSR - 803剂量依赖性地抑制胆碱酯酶,IC50为2.9×10(-6)mol/L,而新斯的明和多潘立酮的IC50分别为2.3×10(-8)mol/L和1.7×10(-5)mol/L。总之,HSR - 803通过拮抗突触后胆碱能神经元上的多巴胺 -2 受体来刺激内源性乙酰胆碱释放,并且HSR - 803的抗胆碱酯酶活性可能导致释放的乙酰胆碱在胆碱能受体部位积聚。因此,HSR - 803有可能增强胃肠道区域的胆碱能活性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验